Friday, January 26, 2024
Symposium 1-5 PM
followed by Reception at 5 PM
Stem Kitchen and Garden, 499 Illinois Street, Mission Bay
RSVP
We have come so far over the past six years. It’s time to celebrate our successes and to chart a course for the future of the Center together. All are welcome.
PROGRAM
OPENING REMARKS
Tippi MacKenzie, Mary Norton, Co-Directors
PRENATAL DIAGNOSIS OF GENETIC ANOMALIES
State of the field: Where we have been and where we are going
Mary Norton, MD, Professor, Obstetrics, Gynecology & Reproductive Sciences
Emerging diagnostic technologies – application to prenatal setting
Kate Swanson, MD, Assistant Professor, Obstetrics, Gynecology & Reproductive Sciences
Barriers, implementation, ethical considerations
Teresa Sparks, MD, MAS, Associate Professor, Obstetrics, Gynecology & Reproductive Sciences
Discussion: Which emerging technologies will change prenatal diagnosis?
Mary Norton (moderator), Teresa Sparks, Kate Swanson, Sara Ackerman, PhD, MPH
Break
PRENATAL THERAPEUTICS FOR GENETIC DISEASES
Setting the stage: Considerations for launching new fetal therapies
Tippi MacKenzie, MD
Enzyme Replacement Therapy: Update on our Phase 1 clinical trial
Emma Canepa, MS, CCRP, Clinical Trials Manager, Center for Maternal-Fetal Precision Medicine
Antisense oligonucleotides: Preclinical data and relevance for CNS disorders
Beltran Borges, MD, Postdoctoral Fellow, MacKenzie Lab
Genome editing: Emerging technologies and their potential application to prenatal therapy
Kyle Cromer, PhD, Assistant Professor, Pediatric Surgery
Discussion: Considerations for planning the next clinical trial
Tippi MacKenzie (moderator), Kyle Cromer, Julia Brown, PhD, Billie Lianoglou, MS, LCGC
RAPID REFLECTIONS
